Grantham, Mayo, Van Otterloo & Co (GMO)
ACLS icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Axcelis ACLS Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ACLS Stock Details ACLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2M Buy
334,786
+11,937
+4% +$1.06M 0.08% 118
2025
Q4 		$25.9M Sell
322,849
-121,014
-27% -$10.1M 0.07% 134
2025
Q3 		$43.3M Buy
443,863
+1,798
+0.4% +$145K 0.12% 88
2025
Q2 		$30.8M Sell
442,065
-137,322
-24% -$7.83M 0.09% 122
2025
Q1 		$28.8M Sell
579,387
-184,682
-24% -$11.7M 0.09% 144
2024
Q4 		$53.4M Buy
764,069
+268,098
+54% +$22.3M 0.17% 58
2024
Q3 		$52M Buy
495,971
+214,987
+77% +$25.1M 0.16% 81
2024
Q2 		$40M Buy
280,984
+5,578
+2% +$643K 0.13% 101
2024
Q1 		$30.7M Buy
275,406
+132,415
+93% +$15.8M 0.11% 135
2023
Q4 		$18.5M Buy
142,991
+23,162
+19% +$3.19M 0.08% 179
2023
Q3 		$19.5M Sell
119,829
-10,677
-8% -$1.88M 0.09% 182
2023
Q2 		$23.9M Sell
130,506
-5,794
-4% -$834K 0.11% 164
2023
Q1 		$18.2M Buy
136,300
+39,216
+40% +$4.61M 0.09% 181
2022
Q4 		$7.7M Sell
97,084
-70,704
-42% -$4.98M 0.04% 278
2022
Q3 		$10.2M Buy
167,788
+94,388
+129% +$6.1M 0.06% 239
2022
Q2 		$4.03M Buy
73,400
+45,500
+163% +$2.64M 0.02% 371
2022
Q1 		$2.11M Buy
+27,900
New +$1.91M 0.01% 443
2020
Q4 		– Sell
-19,000
Closed -$418K – 796
2020
Q3 		$418K Sell
19,000
-35,100
-65% -$895K ﹤0.01% 649
2020
Q2 		$1.51M Sell
54,100
-7,100
-12% -$173K 0.01% 463
2020
Q1 		$1.12M Buy
61,200
+21,300
+53% +$495K 0.01% 481
2019
Q4 		$961K Buy
39,900
+3,700
+10% +$77.9K 0.01% 524
2019
Q3 		$619K Sell
36,200
-10,000
-22% -$160K ﹤0.01% 605
2019
Q2 		$695K Buy
+46,200
New +$825K ﹤0.01% 574

Other funds holding ACLS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ACLS Position: Q1 2026 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) increased its Axcelis (ACLS) stake by 3.7% in Q1 2026, buying an estimated $1.06M and bringing the position to 334,786 shares worth $31.2M. The position accounts for 0.08% of the portfolio, ranked #118.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ACLS in Q2 2019 and has held it in 23 quarters since. The position peaked at $53.4M in Q4 2024. 377 funds tracked by Wall St. Rank hold ACLS as of Q1 2026.

  • Grantham, Mayo, Van Otterloo & Co (GMO) held 334,786 shares of Axcelis worth $31.2M as of Q1 2026.
  • Grantham, Mayo, Van Otterloo & Co (GMO) bought 11,937 Axcelis shares in Q1 2026, an estimated $1.06M.
  • Axcelis made up 0.08% of Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio in Q1 2026, its #118 holding.
  • Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Axcelis in Q2 2019 and has held it in 23 quarters since.
  • Grantham, Mayo, Van Otterloo & Co (GMO)'s Axcelis position peaked at $53.4M in Q4 2024.
  • 377 funds tracked by Wall St. Rank held Axcelis as of Q1 2026.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2026, filed 14 May 2026.